Neurobiological Correlates of the Disposition and Maintenance of Alcoholism

Pharmacopsychiatry

Volumn 36, Issue SUPPL. 3, 2003, Pages

  Heinz, A ^a   Schafer M ^a   Higley, J D ^b   Krystal, J H ^c   Goldman, D ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Alcohol cues; Alcoholism; Candidate genes; Neuroadaptation; Sensitization

Indexed keywords

4 AMINOBUTYRIC ACID; ACAMPROSATE; ALCOHOL; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALTREXONE; OPIATE; OPIATE RECEPTOR; SEROTONIN;

ADAPTATION; ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ATAXIA; BEHAVIOR; COGNITIVE DEFECT; CONFERENCE PAPER; DETOXIFICATION; DISEASE PREDISPOSITION; DOPAMINE RELEASE; ENZYME INHIBITION; EUPHORIA; HUMAN; INTOXICATION; MOTIVATION; NEUROBIOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RELAPSE; SEDATION; SENSITIZATION; TRANQUILIZING ACTIVITY;

ACUTE DISEASE; ALCOHOLISM; BRAIN; CHRONIC DISEASE; DOPAMINE; DRUG TOLERANCE; ETHANOL; GAMMA-AMINOBUTYRIC ACID; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; RECURRENCE; REWARD; RISK FACTORS; SEROTONIN; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION;

EID: 17644440887     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Abi-Dargham A, Krystal JH, Anjilvel S, Scanley BE, Zoghbi S, Baldwin RM, et al. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. Am J Psychiatry 1998; 155: 1550-1555
2. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacology 1994; 2: 244-68
3. Barr CS, Newman TK, Becker ML, Champoux M, Lesch KP, Suomi SJ, et al. Serotonin transporter gene variation is associated with alcohol sensitivity in rhesus macaques exposed to early-life stress. Alc Clin Exp Res 2003; 27: 812-817
4. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998; 28: 309-369
5. Bien TH, Miller WR, Tonigan SJ. Brief interventions for alcohol problems: a review. Addiction 1993; 88: 315-336
6. Clarke AS, Hedeker DR, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW. Rearing experiments and biogenic amine activity in infant rhesus monkeys. Biol Psychiat 1996; 40: 338-352
7. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: 410-416
8. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 1988; 5: 5274-5278
9. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Dependence 1995; 38: 95-137
10. Doudet D, Hommer D, Higley JD, Andreason PJ, Moneman R, Suomi SS et al. Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Am J Psychiat 1995; 152: 1782-1787
11. Engberg G, Hajos M. Alcohol withdrawal reaction as a result of adaptive changes of excitatory amino acid receptors. Naunyn-Schmiedebach's Arch Pharmacol 1992; 346: 437-441
12. Heinz A, Higley JD, Jones DW, Gorey JG, Nommer D, Saunders R et al. In vivo association between brainstem serotonin transporters and sensitivity to alcohol intoxication. Am J Psychiat 1998; 155: 1023-1028
13. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-649
14. Heinz A, Jones DW; Gorey J, Bennet A, Suomi SJ, Linnoila M et al. Serotonin transporter availability correlates with alcohol intake in non-human primates. Mol Psychiatry 2003a; 8: 231-234
15. Heinz A, Löber S, Georgi A, Wrase J, Hermann D, Rey ER et al. Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alc Alcohol 2003b; 38: 35-39
16. Higley JD, Suomi SS, Linnoila M. CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacol (Berl) 1991; 103: 551-556
17. Higley JD, Suomi SS, Linnoila M. A non-human primate model of type II excessive alcohol consumption. Part 1 & 2. Alc Clin Exp Res 1996; 20: 629-651
18. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-58
19. Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth P, Stetson P, Trevisan LA, Charney DS. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 1998; 55: 354-360
20. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA. Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001; 345: 1734-1739
21. Krystal JH, Tabakoff B. Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications. In: Davis KL, Charney DS, Coyle JT, Nemeroff C, editors. Psychopharmacology: a fifth generation of progress Philadelphia: Lippincott Williams and Wilkins, 2002: p. 1425-43
22. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC. N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 2003a; 99: 79-94
23. Krystal JH, Petrakis IL, Limoncelli D, Webb E, Gueorgueva R, D'Souza DC et al. Altered NMDA glutamate receptor antagonist response in recovering ethanol dependent patients. Neuropsychopharmacology, 2003b (in press)
24. Krupitsky EM, Burakov AM, Romanova TN, Grinenko NI, Grinenko AY, Fletcher J et al. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology 2001; 25: 936-947
25. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531
26. Mann K, Hermann D, Heinz A. One hundred years of alcoholism: The twentieth century. Alc Alcohol 2000; 35: 10-15
27. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R et al. Neuroimaging in Alcoholism: Ethanol and Brain Damage. Alcohol Clin Exp Res 2001; 25: 104S-109S
28. McBride WJ, Li TK. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 1998; 12: 339-369
29. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-389
30. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. Guilford Press, New York: 1991
31. Miyakawa T, Yagi T, Kitazawa H, Yasuda M, Kawai N, Tsuboi K et al. Fyn-kinase as determinant of ethanol sensitivity: relation to NMDA-receptor function. Science 1997; 278: 698-701
32. Nestler EJ. Molecular neurobiology of drug addiction. Neuropsychopharmacol 1994; 11: 77-87
33. Newlin DB, Thompson JB. Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol Bull 1990; 108: 383-402
34. Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedrazza M, Abrams DB. Relevance of cue reactivity to understanding alcohol and smoking relapse. J Abnormal Psychol 1988; 97: 133-152
35. O'Brien C, Childress AR, Ehrman R, Robbins SJ. Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 1998; 12: 15-22
36. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53: 217-224
37. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. Concentrations of monoamine metabolism in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. J Psychiat Res 1986; 20: 19-29
38. Petrakis IP, Limoncelli D, Gueorguieva R, Boutros NN, Trevisan L, Gelernter J et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry, 2003 (in press)
39. Pollock VE. Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. Am J Psychiatry 1992; 149: 534-1538
40. Sass H, Soyka M, Mann K, Zieglgänsberger W. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996; 53: 673-680
41. Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiat 1996; 53: 202-210
42. α6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiat 1999; 45: 647-651
43. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275: 1593-1599
44. Siegel S, Hinson RE, Krank MD, McCully J. Heroin "overdose" death: contribution of drug-associated environmental cues. Science 1982; 216: 436-437
45. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogeneous opioid systems modulate the mesolimbic dopaminergic pathway. Proceed Nat Acad Science USA 1992; 89: 2046-2050
46. Spanagel R, Zieglgänsberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997; 18: 54-59
47. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. American Journal of Psychiatry 1995; 152: 332-340
48. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry 1995; 152: 613-615
49. Wienberg G. Die vergessene Mehrheit. Zur Realität der Versorgung alkohol-und medikamentenabhängiger Patienten. Psychiatrie Verlag, Berlin: 1992
50. Wiesbeck GA, Weijers HG, Lesch OM, Glaser T, Toennis PJ, Böning J. Flupentixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alc Alcoholism 2001; 36: 329-334
51. Wise RA. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnormal Psychol 1988; 97: 118-132